322 related articles for article (PubMed ID: 22030372)
1. Functional pentameric formation via coexpression of the Escherichia coli heat-labile enterotoxin B subunit and its fusion protein subunit with a neutralizing epitope of ApxIIA exotoxin improves the mucosal immunogenicity and protection against challenge by Actinobacillus pleuropneumoniae.
Kim JM; Park SM; Kim JA; Park JA; Yi MH; Kim NS; Bae JL; Park SG; Jang YS; Yang MS; Kim DH
Clin Vaccine Immunol; 2011 Dec; 18(12):2168-77. PubMed ID: 22030372
[TBL] [Abstract][Full Text] [Related]
2. Induction of antigen-specific immune responses by oral vaccination with Saccharomyces cerevisiae expressing Actinobacillus pleuropneumoniae ApxIIA.
Shin SJ; Bae JL; Cho YW; Lee DY; Kim DH; Yang MS; Jang YS; Yoo HS
FEMS Immunol Med Microbiol; 2005 Feb; 43(2):155-64. PubMed ID: 15681145
[TBL] [Abstract][Full Text] [Related]
3. Production of Escherichia coli heat labile toxin (LT) B subunit in soybean seed and analysis of its immunogenicity as an oral vaccine.
Moravec T; Schmidt MA; Herman EM; Woodford-Thomas T
Vaccine; 2007 Feb; 25(9):1647-57. PubMed ID: 17188785
[TBL] [Abstract][Full Text] [Related]
4. Nasal immunization with major epitope-containing ApxIIA toxin fragment induces protective immunity against challenge infection with Actinobacillus pleuropneumoniae in a murine model.
Seo KW; Kim SH; Park J; Son Y; Yoo HS; Lee KY; Jang YS
Vet Immunol Immunopathol; 2013 Jan; 151(1-2):102-12. PubMed ID: 23200821
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of recombinant Lactobacillus casei-expressing F4 (K88) fimbrial adhesin FaeG in conjunction with a heat-labile enterotoxin A (LTAK63) and heat-labile enterotoxin B (LTB) of enterotoxigenic Escherichia coli as an oral adjuvant in mice.
Yu M; Qi R; Chen C; Yin J; Ma S; Shi W; Wu Y; Ge J; Jiang Y; Tang L; Xu Y; Li Y
J Appl Microbiol; 2017 Feb; 122(2):506-515. PubMed ID: 27860074
[TBL] [Abstract][Full Text] [Related]
6. The immunogenicity of fusion protein linking the carboxyl terminus of the B subunit of Shiga toxin 2 to the B subunit of E. coli heat-labile enterotoxin.
Ran XQ; Wang HZ; Liu JJ; Li S; Wang JF
Vet Microbiol; 2008 Feb; 127(1-2):209-15. PubMed ID: 17920213
[TBL] [Abstract][Full Text] [Related]
7. Protection of mice against enterotoxigenic E. coli by immunization with a polyvalent enterotoxin comprising a combination of LTB, STa, and STb.
You J; Xu Y; He M; McAllister TA; Thacker PA; Li X; Wang T; Jin L
Appl Microbiol Biotechnol; 2011 Mar; 89(6):1885-93. PubMed ID: 21085949
[TBL] [Abstract][Full Text] [Related]
8. Induction of protective immune responses against challenge of Actinobacillus pleuropneumoniae by oral administration with Saccharomyces cerevisiae expressing Apx toxins in pigs.
Shin MK; Kang ML; Jung MH; Cha SB; Lee WJ; Kim JM; Kim DH; Yoo HS
Vet Immunol Immunopathol; 2013 Jan; 151(1-2):132-9. PubMed ID: 23206402
[TBL] [Abstract][Full Text] [Related]
9. Oral immunization of mice with Saccharomyces cerevisiae expressing a neutralizing epitope of ApxIIA exotoxin from Actinobacillus pleuropneumoniae induces systemic and mucosal immune responses.
Shin MK; Lee WJ; Jung MH; Cha SB; Shin SW; Yoo A; Kim DH; Yoo HS
Microbiol Immunol; 2013 Jun; 57(6):417-25. PubMed ID: 23773020
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of Actinobacillus ApxIA toxin epitopes fused to the E. coli heat-labile enterotoxin B subunit.
Bagdasarian MM; Nagai M; Frey J; Bagdasarian M
Vaccine; 1999 Feb; 17(5):441-7. PubMed ID: 10073721
[TBL] [Abstract][Full Text] [Related]
11. Expression and immunogenicity of enterotoxigenic Escherichia coli heat-labile toxin B subunit in transgenic rice callus.
Kim TG; Kim BG; Kim MY; Choi JK; Jung ES; Yang MS
Mol Biotechnol; 2010 Jan; 44(1):14-21. PubMed ID: 19657748
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of a fusion protein comprising coli surface antigen 3 and labile B subunit of enterotoxigenic Escherichia coli.
Alerasol M; Mousavi Gargari SL; Nazarian S; Bagheri S
Iran Biomed J; 2014; 18(4):212-218. PubMed ID: 25326019
[TBL] [Abstract][Full Text] [Related]
13. Induction of protective immune responses against the challenge of Actinobacillus pleuropneumoniae by the oral administration of transgenic tobacco plant expressing ApxIIA toxin from the bacteria.
Lee KY; Kim DH; Kang TJ; Kim J; Chung GH; Yoo HS; Arntzen CJ; Yang MS; Jang YS
FEMS Immunol Med Microbiol; 2006 Dec; 48(3):381-9. PubMed ID: 17054716
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of protective immune responses by oral vaccination with Saccharomyces cerevisiae expressing recombinant Actinobacillus pleuropneumoniae ApxIA or ApxIIA in mice.
Shin SJ; Shin SW; Kang ML; Lee DY; Yang MS; Jang YS; Yoo HS
J Vet Sci; 2007 Dec; 8(4):383-92. PubMed ID: 17993753
[TBL] [Abstract][Full Text] [Related]
15. Expression of Escherichia coli Heat-Labile Enterotoxin B Subunit in Centella (Centella asiatica (L.) Urban) via Biolistic Transformation.
Loc NH; Tung NV; Kim PTA; Yang MS
Curr Pharm Biotechnol; 2020; 21(10):973-979. PubMed ID: 32101119
[TBL] [Abstract][Full Text] [Related]
16. Immune response characterization and vaccine potential of a recombinant chimera comprising B-cell epitope of Aeromonas hydrophila outer membrane protein C and LTB.
Sharma M; Dixit A
Vaccine; 2016 Dec; 34(50):6259-6266. PubMed ID: 27832917
[TBL] [Abstract][Full Text] [Related]
17. Surface-displayed expression of a neutralizing epitope of ApxIIA exotoxin in Saccharomyces cerevisiae and oral administration of it for protective immune responses against challenge by Actinobacillus pleuropneumoniae.
Kim JM; Jung DI; Eom YJ; Park SM; Yoo HS; Jang YS; Yang MS; Kim DH
Biosci Biotechnol Biochem; 2010; 74(7):1362-7. PubMed ID: 20622458
[TBL] [Abstract][Full Text] [Related]
18. Genetic and antigenic characteristics of ApxIIA and ApxIIIA from Actinobacillus pleuropneumoniae serovars 2, 3, 4, 6, 8 and 15.
To H; Nagai S; Iwata A; Koyama T; Oshima A; Tsutsumi N
Microbiol Immunol; 2016 Jul; 60(7):447-58. PubMed ID: 27211905
[TBL] [Abstract][Full Text] [Related]
19. A tripartite fusion, FaeG-FedF-LT(192)A2:B, of enterotoxigenic Escherichia coli (ETEC) elicits antibodies that neutralize cholera toxin, inhibit adherence of K88 (F4) and F18 fimbriae, and protect pigs against K88ac/heat-labile toxin infection.
Ruan X; Liu M; Casey TA; Zhang W
Clin Vaccine Immunol; 2011 Oct; 18(10):1593-9. PubMed ID: 21813665
[TBL] [Abstract][Full Text] [Related]
20. Secretory expression and purification of recombinant Escherichia coli heat-labile enterotoxin B subunit and its applications on intranasal vaccination of hantavirus.
Cao S; Zhang Y; Liu F; Wang Q; Zhang Q; Liu Q; Li C; Liang M; Li D
Mol Biotechnol; 2009 Feb; 41(2):91-8. PubMed ID: 19089660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
